VIVOPHARM, a CGI company (NASDAQ:CGIX), is a successful and fast-growing precision contract research organization (CRO) providing integrated preclinical services from bench to bedside worldwide. We use our experience and expertise to assist in the planning of and conducting tailored studies, from discovery stages through to clinical development and beyond. We’re a unique IO precision service organization active in per-clinical and clinical services. All work is carried out under well-defined standard operating procedures (SOPs) by highly qualified technicians in state of-the-art laboratories in seven locations.
Find out more: www.vivopharm.com.au